The U.S. District Court for the District of Delaware has granted biotech developer DexCom a stay in the patent infringement case filed against it by rival Abbott Laboratories. The court granted the stay pending re-examination of the patents in question by the U.S. Patent and Trademark Office. Abbott has filed a separate action in the same federal court alleging infringement of three additional patents mentioned in the amendment after the court dismissed a request to add the patents to the lawsuit.
August 21, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
DexCom Inc., a developer of tests that measure blood sugar levels, said Friday a Delaware court has granted a stay in the patent infringement case filed against it by biotech company Abbott Laboratories Inc.
The U.S. District Court for the District of Delaware granted the stay pending re-examination of the patents in question by the United States Patent and Trademark Office.
Presented by BigVoodoo
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
New York boutique law firm currently seeking an attorney with substantive knowledge and at least three years experience litigating in New Yo...
LOGS Legal Group LLP is looking to add a Managing Attorney to our Cincinnati, Ohio office. JOB TITLE: Managing Attorney BUSINESS UNIT: Le...
Capehart Scatchard seeks a personal injury defense litigation associate with 1-4 years experience. Hybrid remote work permitted. Must be ad...
